Hospira acquires Orchid's penicillin and penems API business
This article was originally published in Scrip
Executive Summary
Hospira is acquiring Orchid Chemicals & Pharmaceuticals' penicillin and penem active pharmaceutical ingredients (API) business and Indian facility together with the associated process R&D infrastructure for about $200 million, with an eye on vertical integration aspects and securing API supplies.